HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now

(2011) M. M. Hsieh et al.   BLOOD

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

(2011) C. G. Brunstein et al.   BLOOD

Desensitization in HLA-Incompatible Kidney Recipients and Survival

(2011) Robert A. Montgomery et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: Current Practice and Emerging Trends

(2011) S. Shenoy   Hematology-American Society of Hematology Education Program

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease

(2010) M. L. Hulbert et al.   BLOOD

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

(2010) P. J. Shaw et al.   BLOOD

Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review

(2010) Ying-Jun Chang et al.   CLINICAL TRANSPLANTATION

High-dose cyclophosphamide for graft-versus-host disease prevention

(2010) Leo Luznik et al.   CURRENT OPINION IN HEMATOLOGY

Stem-Cell Transplantation for Sickle Cell Disease

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Blood and marrow transplantation for sickle cell disease: overcoming barriers to success

(2009) Javier Bolaños-Meade et al.   CURRENT OPINION IN ONCOLOGY

Cyclophosphamide and cancer: golden anniversary

(2009) Ashkan Emadi et al.   Nature Reviews Clinical Oncology

Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease

(2009) Matthew M. Hsieh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paucity of HLA-Identical Unrelated Donors for African-Americans with Hematologic Malignancies: The Need for New Donor Options

(2008) Alexander Dew et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

(2008) R A Brodsky et al.   BONE MARROW TRANSPLANTATION